发明名称 |
Pharmaceutical formulation |
摘要 |
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant. |
申请公布号 |
US9029423(B2) |
申请公布日期 |
2015.05.12 |
申请号 |
US201314074067 |
申请日期 |
2013.11.07 |
申请人 |
GW Pharma Limited |
发明人 |
Whittle Brian Anthony |
分类号 |
A01N65/00;A61K36/00;A61K9/00;A61K31/05 |
主分类号 |
A01N65/00 |
代理机构 |
Wolf, Greenfield & Sacks, P.C. |
代理人 |
Wolf, Greenfield & Sacks, P.C. |
主权项 |
1. A pharmaceutical formulation consisting essentially of one or more cannabinoids, ethanol, propylene glycol and less than 5% water. |
地址 |
Salisbury GB |